A 50-year-old woman presented with a pancreatic tumor and multiple hepatic tumors identified via computed tomography (CT). The patient had undergone surgical resection for colon cancer 6 years earlier, followed by resection of a metastatic lung tumor 3 years ago. In the current presentation, primary pancreatic cancer with metastatic hepatic tumors was initially suspected. However, the possibility of previously resected colon cancer metastasizing to the pancreas also had to be considered. CT findings alone could not make this distinction. Therefore, endoscopic ultrasound-guided fine-needle aspiration was performed. Histopathological examination of the pancreatic tumor indicated adenocarcinoma, with features similar to those of the previously resected colon cancer. Immunohistochemical staining was negative for cytokeratin 7 but positive for cytokeratin 20, caudal-type homeobox 2, and special AT-rich sequence-binding protein 2. These findings indicated a pancreatic metastasis of colonic origin. In addition, a percutaneous ultrasound-guided biopsy of one of the hepatic tumors had histopathological findings that were similar to those of the pancreatic tumor. Hence, the patient was diagnosed with pancreatic and hepatic metastases from the previously resected colon cancer. Chemotherapy was initiated after this diagnosis.
{"title":"Single pancreatic and multiple hepatic metastases developing 6 years after left hemicolectomy for colon cancer: A case report.","authors":"Eisuke Kameoka, Takuto Hikichi, Naoki Konno, Hiroyuki Asama, Kenta Kodama, Jun Nakamura, Daiki Nemoto, Tsunetaka Kato, Takumi Yanagita, Mitsuru Otsuka, Masao Kobayakawa, Kazuhiro Tasaki, Hiromasa Ohira","doi":"10.5387/fms.25-00017","DOIUrl":"https://doi.org/10.5387/fms.25-00017","url":null,"abstract":"<p><p>A 50-year-old woman presented with a pancreatic tumor and multiple hepatic tumors identified via computed tomography (CT). The patient had undergone surgical resection for colon cancer 6 years earlier, followed by resection of a metastatic lung tumor 3 years ago. In the current presentation, primary pancreatic cancer with metastatic hepatic tumors was initially suspected. However, the possibility of previously resected colon cancer metastasizing to the pancreas also had to be considered. CT findings alone could not make this distinction. Therefore, endoscopic ultrasound-guided fine-needle aspiration was performed. Histopathological examination of the pancreatic tumor indicated adenocarcinoma, with features similar to those of the previously resected colon cancer. Immunohistochemical staining was negative for cytokeratin 7 but positive for cytokeratin 20, caudal-type homeobox 2, and special AT-rich sequence-binding protein 2. These findings indicated a pancreatic metastasis of colonic origin. In addition, a percutaneous ultrasound-guided biopsy of one of the hepatic tumors had histopathological findings that were similar to those of the pancreatic tumor. Hence, the patient was diagnosed with pancreatic and hepatic metastases from the previously resected colon cancer. Chemotherapy was initiated after this diagnosis.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":" ","pages":""},"PeriodicalIF":0.9,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144993861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aim: To clarify the frequency and characteristics of patients with attention deficit hyperactivity disorder (ADHD) born with low birth weight (LBW), very low birth weight (VLBW), small for gestational age (SGA), or preterm, we examined the clinical characteristics of ADHD patients.
Methods: We collected data for 168 ADHD children, and the patients were retrospectively divided into each group according to birth weight, height, and gestational age.
Results: 1) Patients with ADHD born with LBW, VLBW, SGA, or preterm accounted for 10.1%, 3.0%, 3.6%, or 6.5% of all patients, respectively. 2) ADHD-RS scores for hyperactivity disorder and the frequency of patients requiring ADHD drugs in the LBW infant group were higher than those in the non-LBW infant group. 3) ADHD-RS scores for hyperactivity disorder and total in the VLBW infant group were higher than those in the non-VLBW infant (birth weight:1,500-2,500 g) group. 4) The ADHD scores for attention-deficit and trouble score at the most recent follow-up patients born with SGA were higher than for non-SGA patients.
Conclusions: These results suggest that it is necessary to pay attention to the appearance of neurodevelopment disorders such as ADHD when monitoring the progress of patients born with LBW or VLBW, and it is important to provide more appropriate management and therapeutic guidance for patients born with VLBW or SGA.
{"title":"Clinical characteristics of pediatric attention deficit hyperactivity disorder patients born with low birth weight, small for gestational age, or preterm.","authors":"Yukihiko Kawasaki, Yuichi Suzuki, Kyohei Miyazaki, Naoko Suzuki, Megumi Hoshina, Asako Kato, Hiroyuki Morita, Hayato Go","doi":"10.5387/fms.25-00021","DOIUrl":"https://doi.org/10.5387/fms.25-00021","url":null,"abstract":"<p><strong>Aim: </strong>To clarify the frequency and characteristics of patients with attention deficit hyperactivity disorder (ADHD) born with low birth weight (LBW), very low birth weight (VLBW), small for gestational age (SGA), or preterm, we examined the clinical characteristics of ADHD patients.</p><p><strong>Methods: </strong>We collected data for 168 ADHD children, and the patients were retrospectively divided into each group according to birth weight, height, and gestational age.</p><p><strong>Results: </strong>1) Patients with ADHD born with LBW, VLBW, SGA, or preterm accounted for 10.1%, 3.0%, 3.6%, or 6.5% of all patients, respectively. 2) ADHD-RS scores for hyperactivity disorder and the frequency of patients requiring ADHD drugs in the LBW infant group were higher than those in the non-LBW infant group. 3) ADHD-RS scores for hyperactivity disorder and total in the VLBW infant group were higher than those in the non-VLBW infant (birth weight:1,500-2,500 g) group. 4) The ADHD scores for attention-deficit and trouble score at the most recent follow-up patients born with SGA were higher than for non-SGA patients.</p><p><strong>Conclusions: </strong>These results suggest that it is necessary to pay attention to the appearance of neurodevelopment disorders such as ADHD when monitoring the progress of patients born with LBW or VLBW, and it is important to provide more appropriate management and therapeutic guidance for patients born with VLBW or SGA.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":" ","pages":""},"PeriodicalIF":0.9,"publicationDate":"2025-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144973420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: This study investigated whether preoperative patient characteristics and surgery-related factors affect postoperative de novo overactive bladder (OAB) after robot-assisted radical prostatectomy (RARP), and identified three predictive markers.
Methods: Patients without preoperative OAB who underwent RARP at our hospital between February 2013 and October 2020 were included. At 12 months post-RARP, patients were divided into OAB-free and de novo OAB groups based on the presence of overactive bladder. Preoperative patient characteristics and surgery-related factors were compared between the two groups.
Results: A total of 404 patients were analyzed (OAB-free group, 338; de novo OAB group, 66). The preoperative Overactive Bladder Symptom Score (OABSS) and the percentage of patients with dyslipidemia were significantly higher in the de novo OAB group than in the OAB-free group (OABSS, 3.2 ± 1.6 points vs 2.1 ± 1.4, P<0.01; dyslipidemia, 45.5% vs 32.0%, P=0.04). Nerve-sparing surgery was significantly less common in the de novo OAB group (10.6% vs 27.1%, P<0.01). Preoperative age, blood pressure, BMI, HbA1c, uroflowmetry parameters, prostate volume, operative time and blood loss showed no significant differences between two groups.
Conclusions: High preoperative OABSS, preoperative dyslipidemia and non-nerve-sparing surgery may be predictive markers for de novo OAB after RARP.
{"title":"De novo overactive bladder after robot-assisted radical prostatectomy is predicted by a high preoperative overactive bladder symptom score, preoperative dyslipidemia, and non-nerve-sparing surgery.","authors":"Hitomi Imai, Hidenori Akaihata, Yuki Harigane, Kei Yaginuma, Satoru Meguro, Ruriko Honda-Takinami, Kanako Matsuoka, Seiji Hoshi, Junya Hata, Yuichi Sato, Soichiro Ogawa, Motohide Uemura, Yoshiyuki Kojima","doi":"10.5387/fms.24-00057","DOIUrl":"10.5387/fms.24-00057","url":null,"abstract":"<p><strong>Objectives: </strong>This study investigated whether preoperative patient characteristics and surgery-related factors affect postoperative de novo overactive bladder (OAB) after robot-assisted radical prostatectomy (RARP), and identified three predictive markers.</p><p><strong>Methods: </strong>Patients without preoperative OAB who underwent RARP at our hospital between February 2013 and October 2020 were included. At 12 months post-RARP, patients were divided into OAB-free and de novo OAB groups based on the presence of overactive bladder. Preoperative patient characteristics and surgery-related factors were compared between the two groups.</p><p><strong>Results: </strong>A total of 404 patients were analyzed (OAB-free group, 338; de novo OAB group, 66). The preoperative Overactive Bladder Symptom Score (OABSS) and the percentage of patients with dyslipidemia were significantly higher in the de novo OAB group than in the OAB-free group (OABSS, 3.2 ± 1.6 points vs 2.1 ± 1.4, P<0.01; dyslipidemia, 45.5% vs 32.0%, P=0.04). Nerve-sparing surgery was significantly less common in the de novo OAB group (10.6% vs 27.1%, P<0.01). Preoperative age, blood pressure, BMI, HbA1c, uroflowmetry parameters, prostate volume, operative time and blood loss showed no significant differences between two groups.</p><p><strong>Conclusions: </strong>High preoperative OABSS, preoperative dyslipidemia and non-nerve-sparing surgery may be predictive markers for de novo OAB after RARP.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":" ","pages":"169-175"},"PeriodicalIF":0.9,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12360890/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144045231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: To investigate the effect of dyslipidemia on the lower urinary tract function by examining the LDL-C/HDL-C ratio in patients without bladder outlet obstruction (BOO).
Methods: Patients who underwent urodynamic study before robot-assisted radical prostatectomy were included. Exclusion criteria were diabetes mellitus (HbA1c > 6.2%) and BOO (Schäfer nomogram obstruction III - V). The association between the preoperative LDL-C/HDL-C ratio and urodynamic findings were analyzed. Patients were divided into two groups based on Schäfer nomogram: weak contraction group (W-, W+, N-) and strong contraction group (N+, ST) to assess the relationship between the LDL-C/HDL-C ratio and bladder contraction.
Results: A total of 52 patients entered the study. The LDL-C/HDL-C ratio was 2.4 ± 0.8. The preoperative international prostate symptom score was mild (6.7 ± 5.6). Voided volume was significantly positively associated with the LDL-C/HDL-C ratio (P=0.041). The LDL-C/HDL-C ratio was significantly less in the strong contraction group than in the weak contraction group (P=0.047). Receiver operating characteristic (ROC) analysis showed a cut-off value of 2.15 for the LDL-C/HDL-C ratio in predicting weak bladder contraction.
Conclusions: Dyslipidemia-induced lower urinary tract dysfunction (LUTD) showed less bladder contractility with larger voided volume. The LDL-C/HDL-C ratio ≥ 2.15 may be a useful marker of dyslipidemia-induced LUTD.
{"title":"Serum low density lipoprotein cholesterol / high density lipoprotein cholesterol ratio predicts lower urinary tract dysfunction related dyslipidemia.","authors":"Yuki Harigane, Hidenori Akaihata, Kei Yaginuma, Hitomi Imai, Satoru Meguro, Ruriko Takinami, Kanako Matsuoka, Junya Hata, Yuichi Sato, Soichiro Ogawa, Yoshiyuki Kojima","doi":"10.5387/fms.24-00056","DOIUrl":"10.5387/fms.24-00056","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the effect of dyslipidemia on the lower urinary tract function by examining the LDL-C/HDL-C ratio in patients without bladder outlet obstruction (BOO).</p><p><strong>Methods: </strong>Patients who underwent urodynamic study before robot-assisted radical prostatectomy were included. Exclusion criteria were diabetes mellitus (HbA1c > 6.2%) and BOO (Schäfer nomogram obstruction III - V). The association between the preoperative LDL-C/HDL-C ratio and urodynamic findings were analyzed. Patients were divided into two groups based on Schäfer nomogram: weak contraction group (W-, W+, N-) and strong contraction group (N+, ST) to assess the relationship between the LDL-C/HDL-C ratio and bladder contraction.</p><p><strong>Results: </strong>A total of 52 patients entered the study. The LDL-C/HDL-C ratio was 2.4 ± 0.8. The preoperative international prostate symptom score was mild (6.7 ± 5.6). Voided volume was significantly positively associated with the LDL-C/HDL-C ratio (P=0.041). The LDL-C/HDL-C ratio was significantly less in the strong contraction group than in the weak contraction group (P=0.047). Receiver operating characteristic (ROC) analysis showed a cut-off value of 2.15 for the LDL-C/HDL-C ratio in predicting weak bladder contraction.</p><p><strong>Conclusions: </strong>Dyslipidemia-induced lower urinary tract dysfunction (LUTD) showed less bladder contractility with larger voided volume. The LDL-C/HDL-C ratio ≥ 2.15 may be a useful marker of dyslipidemia-induced LUTD.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":" ","pages":"163-168"},"PeriodicalIF":0.9,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12342219/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143732288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-03Epub Date: 2025-03-06DOI: 10.5387/fms.24-00046
Naokazu Inoue
The fusion between spermatozoon and oocyte represents the final stage of fertilization in mammals. Since only one of the extremely large number of spermatozoa fertilizes the oocyte, there should be a strictly regulated molecular mechanism in gamete fusion. Oocyte CD9 was first identified as a key factor for gamete fusion, followed by sperm IZUMO1 and oocyte IZUMO1 receptor JUNO. Since 2020, with the recent emergence of genome editing technologies, new gamete fusion sperm factors, SPACA6, TMEM95, FIMP, SOF1, DCST1, and DCST2, have been reported one after another. In this review, I would like to give an overview of mammalian gamete fusion based on the latest findings on these factors.
{"title":"Molecular mechanisms leading to gamete fusion.","authors":"Naokazu Inoue","doi":"10.5387/fms.24-00046","DOIUrl":"10.5387/fms.24-00046","url":null,"abstract":"<p><p>The fusion between spermatozoon and oocyte represents the final stage of fertilization in mammals. Since only one of the extremely large number of spermatozoa fertilizes the oocyte, there should be a strictly regulated molecular mechanism in gamete fusion. Oocyte CD9 was first identified as a key factor for gamete fusion, followed by sperm IZUMO1 and oocyte IZUMO1 receptor JUNO. Since 2020, with the recent emergence of genome editing technologies, new gamete fusion sperm factors, SPACA6, TMEM95, FIMP, SOF1, DCST1, and DCST2, have been reported one after another. In this review, I would like to give an overview of mammalian gamete fusion based on the latest findings on these factors.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":" ","pages":"141-145"},"PeriodicalIF":0.9,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12342222/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143587312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-03Epub Date: 2025-04-01DOI: 10.5387/fms.24-00049
Kazuki Sugaya, Takeyasu Kakamu, Ken Iseki, Arifumi Hasegawa
Disasters are becoming more common, and their types are more varied. This study investigated the extent to which medical students would like to be engaged in different types of disasters to help recruit personnel for future disaster medicine based on a web-based survey. The study was conducted using existing data. The results revealed that students' intention to engage in chemical, biological, radiological, nuclear, and explosive (CBRNE) disasters was lower than that for natural and human-made disasters. Further, differences in the intention to engage and perceptions of disasters were observed. We hypothesized that the low intention to engage in CBRNE disasters was due, in part, to the fear of unknown hazards and the belief that disaster response was not part of the university's mission. Thus, each university should train healthcare professionals to imagine the social needs of risk and educate students about their intention to engage. This can be done by showing them how to respond to disasters in the social context of societal demands in case of future crises.
{"title":"Differences in perceptions and intentions to engage in various disasters by curriculum and social roles of belonging: A cross-sectional study of japanese medical students.","authors":"Kazuki Sugaya, Takeyasu Kakamu, Ken Iseki, Arifumi Hasegawa","doi":"10.5387/fms.24-00049","DOIUrl":"10.5387/fms.24-00049","url":null,"abstract":"<p><p>Disasters are becoming more common, and their types are more varied. This study investigated the extent to which medical students would like to be engaged in different types of disasters to help recruit personnel for future disaster medicine based on a web-based survey. The study was conducted using existing data. The results revealed that students' intention to engage in chemical, biological, radiological, nuclear, and explosive (CBRNE) disasters was lower than that for natural and human-made disasters. Further, differences in the intention to engage and perceptions of disasters were observed. We hypothesized that the low intention to engage in CBRNE disasters was due, in part, to the fear of unknown hazards and the belief that disaster response was not part of the university's mission. Thus, each university should train healthcare professionals to imagine the social needs of risk and educate students about their intention to engage. This can be done by showing them how to respond to disasters in the social context of societal demands in case of future crises.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":" ","pages":"177-185"},"PeriodicalIF":0.9,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12342221/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143732367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: The COVID-19 pandemic has had a significant impact on healthcare, including cancer management. This study aimed to investigate the prognostic impact of the COVID-19 pandemic, throughout its duration, on patient care for pancreatic ductal adenocarcinoma (PDAC).
Methods: We collected clinical data of patients with unresectable PDAC who underwent palliative chemotherapy at five medical facilities in Fukushima, Japan. The patients were divided into two groups: group A (nonpandemic cohort) and group B (pandemic cohort). Survival analysis was performed for progression-free survival (PFS) and overall survival (OS) via the Kaplan‒Meier method with the log-rank test.
Results: In total, 249 patients were selected for the analysis. Patients in Group B had significantly greater serum CA19-9 levels and proportions of patients selected for combination therapy; however, we did not find significant differences between the two groups in PFS (Group A vs. Group B: 5.6 months vs. 4.4 months, HR = 0.82 (95% CI, 0.6-1.1), p = 0.17) or OS (14.8 months vs. 12.3 months, HR = 0.81 (95% CI, 0.7-1.3), p = 0.81) in the survival analysis.
Conclusions: We did not observe a negative impact on the prognosis of patients with unresectable PDAC throughout the COVID-19 pandemic.
{"title":"Impact of COVID-19 pandemic on unresectable pancreatic cancer: a regional cohort study in Japan.","authors":"Rei Suzuki, Hiroyuki Asama, Naoki Konno, Ko Watanabe, Hiromichi Imaizumi, Yuichi Waragai, Mitsuru Sugimoto, Yuki Sato, Hiroki Irie, Hiroshi Shimizu, Kentaro Sato, Tadayuki Takagi, Hiromasa Ohira","doi":"10.5387/fms.24-00011","DOIUrl":"10.5387/fms.24-00011","url":null,"abstract":"<p><strong>Background: </strong>The COVID-19 pandemic has had a significant impact on healthcare, including cancer management. This study aimed to investigate the prognostic impact of the COVID-19 pandemic, throughout its duration, on patient care for pancreatic ductal adenocarcinoma (PDAC).</p><p><strong>Methods: </strong>We collected clinical data of patients with unresectable PDAC who underwent palliative chemotherapy at five medical facilities in Fukushima, Japan. The patients were divided into two groups: group A (nonpandemic cohort) and group B (pandemic cohort). Survival analysis was performed for progression-free survival (PFS) and overall survival (OS) via the Kaplan‒Meier method with the log-rank test.</p><p><strong>Results: </strong>In total, 249 patients were selected for the analysis. Patients in Group B had significantly greater serum CA19-9 levels and proportions of patients selected for combination therapy; however, we did not find significant differences between the two groups in PFS (Group A vs. Group B: 5.6 months vs. 4.4 months, HR = 0.82 (95% CI, 0.6-1.1), p = 0.17) or OS (14.8 months vs. 12.3 months, HR = 0.81 (95% CI, 0.7-1.3), p = 0.81) in the survival analysis.</p><p><strong>Conclusions: </strong>We did not observe a negative impact on the prognosis of patients with unresectable PDAC throughout the COVID-19 pandemic.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":" ","pages":"147-153"},"PeriodicalIF":0.9,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12342220/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143587221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Renal arteries vary in their number and arrangement. Accessory renal arteries (ARA), termed by various names in the literature, can arise from different arterial sources and may be single, double, or multiple. Understanding these variations is essential for various medical procedures.
Aim: To determine the presence of ARA in the cadavers of South Indian origin and their origin and termination and to discuss its relevant clinical anatomy.
Materials and methods: This descriptive study utilized 36 adult cadavers of South Indian origin aged between 50 and 80 years. The ARA observed were classified according to their origin and termination. The Chi-square test was used to determine the variation in the distribution of accessory arteries between the sides.
Results: Among the 72 kidneys examined, 27.7% had ARA, with a left-sided preponderance. Most accessory arteries had an aortic origin and hilar or superior polar termination. Various forms of accessory arteries were observed, including those entering the anterior surface of the kidney, a rare phenomenon.
Conclusion: The incidence of accessory arteries supplying the kidney emphasizes the importance of understanding renal vascular anatomy for clinical practice. Anatomical variations play a crucial role in selecting donors for renal transplantation and during various renal interventional procedures.
{"title":"Exploring the occurrence and clinical implications of accessory renal arteries: A descriptive study in South Indian cadavers.","authors":"Manju Bhashini Manoharan, Raviraj Kuppusamy, Manickam Subramanian","doi":"10.5387/fms.24-00021","DOIUrl":"10.5387/fms.24-00021","url":null,"abstract":"<p><strong>Introduction: </strong>Renal arteries vary in their number and arrangement. Accessory renal arteries (ARA), termed by various names in the literature, can arise from different arterial sources and may be single, double, or multiple. Understanding these variations is essential for various medical procedures.</p><p><strong>Aim: </strong>To determine the presence of ARA in the cadavers of South Indian origin and their origin and termination and to discuss its relevant clinical anatomy.</p><p><strong>Materials and methods: </strong>This descriptive study utilized 36 adult cadavers of South Indian origin aged between 50 and 80 years. The ARA observed were classified according to their origin and termination. The Chi-square test was used to determine the variation in the distribution of accessory arteries between the sides.</p><p><strong>Results: </strong>Among the 72 kidneys examined, 27.7% had ARA, with a left-sided preponderance. Most accessory arteries had an aortic origin and hilar or superior polar termination. Various forms of accessory arteries were observed, including those entering the anterior surface of the kidney, a rare phenomenon.</p><p><strong>Conclusion: </strong>The incidence of accessory arteries supplying the kidney emphasizes the importance of understanding renal vascular anatomy for clinical practice. Anatomical variations play a crucial role in selecting donors for renal transplantation and during various renal interventional procedures.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":" ","pages":"155-161"},"PeriodicalIF":0.9,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12342224/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143732284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Human herpesvirus 7 (HHV-7) is ubiquitous and infects most children. Severe HHV-7 infection was considered to be rare. In this case series, we report the clinical findings and clinical courses of three immunocompetent children who had severe HHV-7 infection: two fatal cases of encephalopathy and one patient with severe sequelae after myocarditis. In all three patients, HHV-7 DNA was detected in acute phase specimens, including serum by real-time PCR. In the myocarditis case, HHV-7 DNA was also detected in myocardial tissue, suggesting that HHV-7 was the cause. Patient 1 was a 6-year-old Japanese girl with encephalopathy who died one day after onset. Patient 2 was a 4-year-old Japanese girl with encephalopathy whose absence of brainstem reflexes was confirmed and died 29 days after onset. Patient 3 was a 22-month-old Japanese girl with myocarditis who managed with extracorporeal membrane oxygenation and survived but was left with severe neurological sequelae. Because HHV-7 can cause serious outcomes in children, a virological search for HHV-7 in severe infections needs to be aggressive, and cases should be accumulated.
{"title":"Severe Human Herpesvirus 7 Infection in Healthy Children.","authors":"Hisao Okabe, Masatoki Sato, Sakurako Norito, Kazufumi Yaginuma, Yasushi Saito, Tetsushi Yoshikawa, Mitsuaki Hosoya","doi":"10.5387/fms.24-00010","DOIUrl":"10.5387/fms.24-00010","url":null,"abstract":"<p><p>Human herpesvirus 7 (HHV-7) is ubiquitous and infects most children. Severe HHV-7 infection was considered to be rare. In this case series, we report the clinical findings and clinical courses of three immunocompetent children who had severe HHV-7 infection: two fatal cases of encephalopathy and one patient with severe sequelae after myocarditis. In all three patients, HHV-7 DNA was detected in acute phase specimens, including serum by real-time PCR. In the myocarditis case, HHV-7 DNA was also detected in myocardial tissue, suggesting that HHV-7 was the cause. Patient 1 was a 6-year-old Japanese girl with encephalopathy who died one day after onset. Patient 2 was a 4-year-old Japanese girl with encephalopathy whose absence of brainstem reflexes was confirmed and died 29 days after onset. Patient 3 was a 22-month-old Japanese girl with myocarditis who managed with extracorporeal membrane oxygenation and survived but was left with severe neurological sequelae. Because HHV-7 can cause serious outcomes in children, a virological search for HHV-7 in severe infections needs to be aggressive, and cases should be accumulated.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":" ","pages":"187-194"},"PeriodicalIF":0.9,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12342223/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143587318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abatacept (ABT) is effective in the treatment of rheumatoid arthritis (RA). However, there is no consensus regarding the treatment of patients with RA and idiopathic inflammatory myopathy (IIM). Here, we describe the case of a 55-year-old Japanese female with a 5-year history of RA who developed anti-Jo1 antibody-positive IIM. She developed myalgia and dyspnea while receiving a combination therapy of methotrexate and a Janus kinase inhibitor for RA. Chest computed tomography imaging revealed bilateral middle-to-lower lung frosted shadows. Magnetic resonance imaging of the lower limbs showed a high short tau inversion recovery signal in the bilateral thigh muscle groups. Needle electromyography revealed myogenic changes in the proximal muscles of both the upper and lower extremities. Symmetric proximal muscle weakness, elevated serum muscle enzymes, and the presence of anti-Jo1 antibodies were noted. The diagnosis of IIM was made according to the European Alliance of Associations for Rheumatology diagnostic criteria. The myositis symptoms stabilized with glucocorticoids; however, RA worsened during steroid tapering. After ABT initiation, RA clinical symptoms and functional outcomes improved and myositis remained in remission. In conclusion, ABT may be an effective treatment option for patients with RA and IIM. .
{"title":"Successful treatment of rheumatoid arthritis complicated by anti-Jo-1 antibody-positive myopathy with abatacept: A case report.","authors":"Shuhei Yoshida, Jumpei Temmoku, Kenji Saito, Eiji Suzuki, Takashi Kanno, Yuya Sumichika, Haruki Matsumoto, Yuya Fujita, Naoki Matsuoka, Tomoyuki Asano, Shuzo Sato, Kiyoshi Migita","doi":"10.5387/fms.24-00054","DOIUrl":"10.5387/fms.24-00054","url":null,"abstract":"<p><p>Abatacept (ABT) is effective in the treatment of rheumatoid arthritis (RA). However, there is no consensus regarding the treatment of patients with RA and idiopathic inflammatory myopathy (IIM). Here, we describe the case of a 55-year-old Japanese female with a 5-year history of RA who developed anti-Jo1 antibody-positive IIM. She developed myalgia and dyspnea while receiving a combination therapy of methotrexate and a Janus kinase inhibitor for RA. Chest computed tomography imaging revealed bilateral middle-to-lower lung frosted shadows. Magnetic resonance imaging of the lower limbs showed a high short tau inversion recovery signal in the bilateral thigh muscle groups. Needle electromyography revealed myogenic changes in the proximal muscles of both the upper and lower extremities. Symmetric proximal muscle weakness, elevated serum muscle enzymes, and the presence of anti-Jo1 antibodies were noted. The diagnosis of IIM was made according to the European Alliance of Associations for Rheumatology diagnostic criteria. The myositis symptoms stabilized with glucocorticoids; however, RA worsened during steroid tapering. After ABT initiation, RA clinical symptoms and functional outcomes improved and myositis remained in remission. In conclusion, ABT may be an effective treatment option for patients with RA and IIM. .</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":" ","pages":"195-201"},"PeriodicalIF":0.9,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12342225/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}